Analyst Matthew O'Brien reaffirms an Overweight rating and $420 price target for Stryker, highlighting the potential of its new Mako RPS handheld orthopedic robot to capture cost-sensitive markets and compete with rivals like Zimmer Biomet.
While Bitcoin's sharp correction to nine-month lows triggered massive liquidations and ETF outflows, a deeper look reveals sustained corporate accumulation, state-level adoption proposals, and expanding bank services—painting a picture of a maturing asset class weathering short-term volatility.
Usama Ghanem, an Egyptian student at King's College London, faces imminent deportation after disciplinary action linked to his pro-Palestinian activism. He claims the university's response mirrors the political persecution he fled in Egypt, raising urgent questions about academic freedom and the treatment of international dissent.
Cavco Industries reports robust fiscal Q2 2026 earnings, with revenue up 9.7% year-over-year, driven by double-digit shipment growth in Northern U.S. markets. The company successfully managed a slowdown in the Southeast through operational adjustments and highlighted a significant turnaround in its financial services segment.
Barclays' upgrade of PTC Therapeutics to Overweight has spotlighted the biotech firm's valuation, with shares showing strong momentum but questions lingering over its path to profitability and reliance on a narrow drug portfolio.
Applied Optoelectronics (AAOI) has secured a significant order for its high-speed 800G optical transceivers from a key hyperscale client, coinciding with a strategic expansion of its Texas manufacturing facility to meet surging AI data center demand.
After a staggering multi-year rally, shares of American Superconductor (AMSC) are showing signs of cooling momentum. With a sky-high P/E ratio and a significant gap between its current price and analyst fair value estimates, investors are grappling with a critical question: is this a buying opportunity or a signal to take profits?
Shares of quantum computing pioneer Rigetti Computing have delivered substantial returns over the past year, dramatically outperforming the broader market. Yet, analysts caution that sky-high valuations may have raced far ahead of the company's current commercial reality.
Panama's Supreme Court has declared CK Hutchison's concession to operate the Balboa and Cristóbal ports unconstitutional, derailing a major sale and placing APM Terminals in temporary control. The ruling intensifies geopolitical tensions over control of the strategic Panama Canal.
As speculation intensifies over a potential acquisition of Warner Bros. Discovery by Netflix, short sellers are rapidly retreating from the stock, signaling market confidence in both the deal's completion and regulatory approval.
Panama's Supreme Court has annulled the long-term concession of Hong Kong-based CK Hutchison to operate key ports at the Panama Canal, appointing Denmark's Maersk as temporary administrator. The move follows geopolitical tensions and allegations of unpaid fees.
President Trump nominates Kevin Warsh, a former Fed governor with Wall Street ties, to succeed Jerome Powell as Federal Reserve Chair. His confirmation faces scrutiny amid questions over monetary policy direction and the central bank's political independence.
Congress has approved $23 billion in initial funding for the ambitious Golden Dome missile defense initiative, yet the absence of a detailed spending blueprint from the Pentagon is stalling progress and clouding investment prospects for 2026.
From post-IPO darling to a stock trading near historic lows, Rivian faces a critical five-year window. With new models on the horizon and a major Volkswagen partnership, analysts see a path to growth—if it can navigate fierce competition and persistent losses.
Morgan Stanley reaffirms its Overweight rating on Nvidia with a $250 price target, citing the company's systemic advantage through its Vera Rubin platform and robust hyperscaler spending, despite acknowledging competitive and demand risks.
From a $10 direct listing to a $150 S&P 500 constituent, Palantir's journey has been fueled by the AI boom. As government and commercial demand surge, analysts project staggering growth. But with sky-high valuations, the path forward requires navigating lofty expectations.
American Express reported fourth-quarter earnings that narrowly missed analyst forecasts, yet a modest stock decline reflects investor confidence in its robust guidance and the sustained momentum of its high-end cardmember base.
A Boston federal judge has temporarily blocked the Biden administration's move to terminate Temporary Protected Status for over 5,000 Ethiopians, granting more time for a legal challenge against the decision.
Shares of Allison Transmission Holdings (ALSN) have surged over 35% in three months, reigniting a fierce debate among analysts over whether the stock is overvalued or still trading at a deep discount to its future cash flows.
French biopharma firm Inventiva (ENXTPA:IVA) has delivered a stunning 126% total return to shareholders over the past year, sharply contrasting with losses over a three-year horizon. As the stock experiences short-term pullbacks, analysts debate whether its current €5.23 price reflects future promise or present hype, with a key drug candidate hanging in the balance.
